Science-Led Biopharma Investment Platform

Connecting scientific validation, drug development and global partnering to build investment value.

Explore Our Approach
About Us

Where Scientific Insight Meets Investment and Global Partnering

Protheragen Capital is a science-led biopharma investment platform focused on innovative therapeutics and differentiated investment opportunities across the global biopharma ecosystem.

Our approach combines scientific expertise, drug development capabilities, and global industry insights to support informed investment decisions and long-term value creation. Through rigorous scientific assessment, targeted validation where appropriate, and milestone-oriented development strategies, we aim to identify and advance promising therapeutic innovations.

About Protheragen
Protheragen Capital team or office

Our Investment Lens

Differentiated Science

Scientific rationale and therapeutic potential

Clear Milestones

Defined development goals and measurable progress

Global Potential

Opportunities for strategic partnering and value creation

Our Approach

Connecting Scientific Insight, Development and Global Partnering

We combine rigorous scientific assessment, milestone-focused development planning and global industry perspectives to inform investment decisions and support long-term asset value creation.

Scientific Assessment & Selective Validation

Scientific Assessment & Selective Validation

We evaluate decision-critical scientific evidence and, where appropriate, use targeted validation to inform investment decisions.

Milestone-Focused Development

Milestone-Focused Development

Development planning, specialist execution and staged capital allocation are aligned with defined evidence and budget milestones.

Global Partnering Insight

Global Strategic Partnering Insight

Industry and potential partner feedback help inform asset positioning and pathways to future financing, licensing or strategic transactions.

Investment Flywheel

From Opportunity Sourcing to Value Realization

Our investment approach connects global asset sourcing, scientific assessment, selective validation, capital deployment, milestone-focused development and global partnering to support potential value realization. Experience and industry insights gained throughout the process help inform future investment decisions.

Investment Flywheel: from opportunity sourcing to value realization
Selected Investment

Investing in Differentiated Science

A selected investment reflecting our interest in innovative therapeutic approaches and long-term development potential.

Developing an in situ CAR-macrophage (CAR-M) platform using mRNA-LNP delivery to target multiple tumor-associated antigens in solid tumors, with initial programs in HCC and GBM.

Visit website →
Global Ecosystem

Connecting Science, Capital and Industry

Through our scientific and industry relationships, we engage with biotech companies, researchers, investors and pharmaceutical partners to identify opportunities, assess development potential and explore strategic collaborations.

Scientific Networks

Biopharma Industry

Investment & Partnering

Global network
Insights

The Latest at Protheragen Capital

Partnership agreement
Perspective

Protheragen Capital Announces Investment in RenaBio Therapeutics, Developing In Situ CAR-Macrophage Therapy for Solid Tumors

Protheragen Capital, a science-led biopharma investment platform, today announced its investment in RenaBio Therapeutics, Inc., a Greater Boston–based company developing in situ CAR-macrophage (CAR-M) therapy for solid tumors.

Read More →

From First Insight to Funded Program

We welcome introductions from biotech founders, scientists and asset owners developing differentiated therapeutic innovations. Share a brief introduction, and our senior team will review your proposal and explore ways to support its development.

Submit Your Opportunity  

What We Look For

We evaluate therapeutic opportunities based on four key dimensions:

Scientific Innovation

Novel targets, mechanisms, or modalities.

Differentiated Advantage

Clear advantages over existing therapies.

Validation Data

Evidence supporting scientific feasibility.

Growth Potential

Potential for development and partnerships.

Our Diligence Process

Every proposal receives careful review. We welcome opportunities at all stages, from early concepts to advanced candidates.

1

Submission

A brief introduction to your company or program.

2

Initial Review

Initial assessment by our investment team.

3

Detailed Evaluation

In-depth scientific and development assessment.

4

Next Steps

Discussion of investment or partnership opportunities.

Start a conversation.

For Investors & Co-investors

Connect with our team to discuss fund strategies and co-investment opportunities.

For Founders & Scientists

Submit non-confidential materials for rapid, rigorous evaluation by our investment team.

For Events & Media

Direct all speaking invitations, panel requests, and press inquiries to our team.

For all inquiries, please contact us at

contact@protheragen.capital